This is a "connection" page, showing publications co-authored by David T. Rubin and Tenzin Choden.
Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2022 May; 18(5):265-271.
Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Jan 30.
Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data from a Large Tertiary Center. Clin Gastroenterol Hepatol. 2022 Apr 02.